Clinical investigation in ACS and PCI: shooting in the dark at a moving target.
Dangas
George
G
D054058:Acute Coronary Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000401:mortality; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D019317:Evidence-Based Medicine; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D009204:Myocardial Revascularization; D010875:Pipecolic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D012107:Research Design; D018570:Risk Assessment; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome
D000925:Anticoagulants; D010875:Pipecolic Acids; D013449:Sulfonamides; D001120:Arginine; D013917:Thrombin; C031942:argatroban